Zevra Therapeutics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Zevra Therapeutics, Inc. (ZVRA) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $17.80 million as of 2024-12-31, per its 10-K filed 2025-03-12.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2025-03-12
- 2024-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $17.80M.
- 2024-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $13.90M.
- 2024-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $7.86M.
- 2024-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $11.54M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2024-12-31 | $17.80M 10-K · filed 2025-03-12 | |
| 2024-09-30 | $13.90M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $7.86M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $11.54M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $16.10M 10-K · filed 2025-03-12 | |
| 2023-03-31 | $3.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $10.20M 10-K · filed 2024-04-01 | $1.00K 10-K · filed 2023-03-07 |
| 2022-09-30 | $34.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $56.00K 10-Q · filed 2022-11-10 | |
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-15 | $84.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $25.03M 10-K · filed 2024-04-01 | $306.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $361.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $666.00K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $292.00K 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $255.00K 10-K · filed 2023-03-07 | |
| 2020-09-30 | $153.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $38.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $38.00K 10-Q · filed 2021-08-13 | |
| 2019-12-31 | $96.00K 10-K · filed 2022-03-31 | |
| 2019-09-30 | $269.00K 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $1.44M 10-Q · filed 2020-10-30 | |
| 2019-03-31 | $1.42M 10-Q · filed 2020-08-12 | |
| 2018-12-31 | $1.84M 10-K · filed 2021-03-12 | |
| 2018-09-30 | $7.42M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $11.89M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $17.45M 10-Q · filed 2019-08-13 | |
| 2017-12-31 | $7.71M 10-K · filed 2020-02-28 | |
| 2017-09-30 | $7.00M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $8.31M 10-Q · filed 2018-11-09 | |
| 2017-03-31 | $11.83M 10-Q · filed 2018-08-10 | |
| 2016-12-31 | $4.62M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $7.34M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $6.04M 10-Q · filed 2017-11-09 | |
| 2016-03-31 | $27.48M 10-Q · filed 2017-08-10 | |
| 2015-12-31 | $37.84M 10-K · filed 2018-03-30 | |
| 2015-09-30 | $41.10M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $39.28M 10-Q · filed 2016-11-10 | |
| 2015-03-31 | $17.73M 10-Q · filed 2016-08-11 | |
| 2014-12-31 | $15.97M 10-K · filed 2017-03-10 | |
| 2014-09-30 | $12.74M 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $10.55M 10-Q · filed 2015-11-13 | |
| 2013-12-31 | $2.81M 10-K · filed 2016-03-16 | $2.81M 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |